Share Facebook Twitter LinkedIn Pinterest Email Earnings Snapshot: iQIYI misses Q4 top-line estimates, membership services revenue drops 15%
AngioDynamics signals FY2026 adjusted EBITDA of $10M-$12M while raising net sales guidance to $313.5M-$315.5M (NASDAQ:ANGO)April 2, 2026